CALR and systemic lupus erythematosus: For example, rheumatic symptoms are observed in cancer patients receiving cyclophosphamide/5-fluorouracil combination chemotherapy (40), and the administration of tamoxifen in cancer patients can be associated with the onset of lupus-like symptoms and polyarthritis, and the generation of anti-nuclear antibodies and anti-Ro antibodies (23–25).